<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00636077</url>
  </required_header>
  <id_info>
    <org_study_id>Gambro 1461</org_study_id>
    <nct_id>NCT00636077</nct_id>
  </id_info>
  <brief_title>Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For Hemodialysis</brief_title>
  <official_title>Effect Of Dialysate Flow Rate On Mass Transfer Coefficient - Area (KoA) In Dialyzers With Different Membrane Packing Densities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gambro Renal Products, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Baxter Healthcare Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purposes of this study are to determine if the performance of a dialyzer depends on how
      tightly the hollow fiber membranes are packed in the housing of the dialyzer (the membrane
      packing density) and if that dependence is a function of the dialysate flow rate. The study
      will examine how efficiently three different sized molecules pass through a dialyzer membrane
      at different dialysate flow rates in dialyzers with different membrane packing densities.
      Transfer of urea, phosphorus and beta-2-microglobulin from blood to dialysate will be
      measured during clinical hemodialysis using four different dialyzers, each used at three
      different dialysate flow rates. The data derived from these measurements may provide insight
      into the importance of membrane packing density as a design parameter for hemodialyzers and
      if changing the membrane packing density might provide equivalent performance at a lower
      dialysate flow rate.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of Increased Dialysate Flow Rate on KoA for Urea Between 4 Dialyzers With Different Membrane Packing Densities.</measure>
    <time_frame>During the third treatment with each dialyzer (one time during each trial period week)</time_frame>
    <description>KoA is a constant that describes the efficiency of a dialyzer in removing urea. KoA is determined by surface area of the membrane, the thickness of the membrane and pore size.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of Increased Dialysate Flow Rate on Whole Blood Urea Clearance Between 4 Dialyzers With Different Membrane Packing Densities.</measure>
    <time_frame>During the third treatment with each dialyzer (one time during each trial period week)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of Increased Dialysate Flow Rate on KoA for Phosphorus Between 4 Dialyzers With Different Membrane Packing Densities.</measure>
    <time_frame>During the third treatment with each dialyzer (one time during each trial period week)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of Increased Dialysate Flow Rate on Whole Blood Phosphorus Clearance Between 4 Dialyzers With Different Membrane Packing Densities.</measure>
    <time_frame>During the third treatment with each dialyzer (one time during each trial period week)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of Increased Dialysate Flow Rate on KoA for b2-microglobulin Between 4 Dialyzers With Different Membrane Packing Densities.</measure>
    <time_frame>During the third treatment with each dialyzer (one time during each trial period week)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of Increased Dialysate Flow Rate on Whole Blood B2-microglobulin Clearance Between 4 Dialyzers With Different Membrane Packing Densities.</measure>
    <time_frame>During the third treatment with each dialyzer (one time during each trial period week)</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <condition>Chronic Renal Disease</condition>
  <arm_group>
    <arm_group_label>HD-C4 Big</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>3 consecutive treatments with the HD-C4 Big dialyzer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HD-C4 Small</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>3 consecutive treatments with the HD-C4 Small dialyzer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>F160NR</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>3 consecutive treatments with the F160NR dialyzer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>F200NR</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>3 consecutive treatments with the F200NR dialyzer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Polyflux HD-C4 Big</intervention_name>
    <description>Three consecutive treatments with the HD-C4 Big. During the third treatment, dialyzer clearances of urea, phosphorus and β2-microglobulin will be determined at a blood flow rate of 400 mL/min and dialysate flow rates of 350 mL/min, 500 mL/min and 800 mL/min.</description>
    <arm_group_label>HD-C4 Big</arm_group_label>
    <other_name>Gambro Polyflux HD-C4 Big dialyzer</other_name>
    <other_name>Gambro Revaclear MAX</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HD-C4 Small</intervention_name>
    <description>Three consecutive treatments with the HD-C4 Small. During the third treatment dialyzer clearances of urea, phosphorus and β2-microglobulin will be determined at a blood flow rate of 400 mL/min and dialysate flow rates of 350 mL/min, 500 mL/min and 800 mL/min.</description>
    <arm_group_label>HD-C4 Small</arm_group_label>
    <other_name>Gambro Polyflux HD-C4 Small dialyzer</other_name>
    <other_name>Gambro Revaclear dialyzer</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optiflux 160NR</intervention_name>
    <description>Three consecutive treatments with the HD-C4 Small. During the third treatment dialyzer clearances of urea, phosphorus and β2-microglobulin will be determined at a blood flow rate of 400 mL/min and dialysate flow rates of 350 mL/min, 500 mL/min and 800 mL/min.</description>
    <arm_group_label>F160NR</arm_group_label>
    <other_name>Fresenius Optiflux 160NR</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optiflux 200NR</intervention_name>
    <description>Three consecutive treatments with the HD-C4 Small. During the third treatment dialyzer clearances of urea, phosphorus and β2-microglobulin will be determined at a blood flow rate of 400 mL/min and dialysate flow rates of 350 mL/min, 500 mL/min and 800 mL/min.</description>
    <arm_group_label>F200NR</arm_group_label>
    <other_name>Fresenius Optiflux 200NR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stable hemodialysis patients dialyzing through a native fistula or Gore-Tex graft. The
             access must be capable of delivering a stable blood flow of 400 ml/min.

          -  Age older than 18 years.

          -  Fluid removal requirement less than 3 liters per treatment.

        Exclusion Criteria:

          -  Noncompliance with dialysis regimen.

          -  Hematocrit less than 28%.

          -  Active infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Ward, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Louisville, Kidney Disease Program</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202-1718</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Leypoldt JK, Cheung AK, Agodoa LY, Daugirdas JT, Greene T, Keshaviah PR. Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study. Kidney Int. 1997 Jun;51(6):2013-7.</citation>
    <PMID>9186896</PMID>
  </reference>
  <reference>
    <citation>Ouseph R, Ward RA. Increasing dialysate flow rate increases dialyzer urea mass transfer-area coefficients during clinical use. Am J Kidney Dis. 2001 Feb;37(2):316-20.</citation>
    <PMID>11157372</PMID>
  </reference>
  <reference>
    <citation>Michaels AS. Operating parameters and performance criteria for hemodialyzers and other membrane-separation devices. Trans Am Soc Artif Intern Organs. 1966;12:387-92.</citation>
    <PMID>5960730</PMID>
  </reference>
  <reference>
    <citation>Ward RA, Ouseph R: Comparative evaluation of small and large molecule removal during hemodialysis with Polyflux-S and Fresenius polysulfone membranes. Report to Gambro Renal Products, February 6, 2003.</citation>
  </reference>
  <reference>
    <citation>Ward RA, Ouseph R: A comparison of urea, phosphorus and b2-microglobulin removal during hemodialysis with dialyzers containing Polyflux H and Fresenius Optiflux membranes. Report to Gambro Renal Products, August 29, 2005.</citation>
  </reference>
  <reference>
    <citation>Leypoldt JK, Cheung AK, Chirananthavat T, Gilson JF, Kamerath CD, Deeter RB. Hollow fiber shape alters solute clearances in high flux hemodialyzers. ASAIO J. 2003 Jan-Feb;49(1):81-7.</citation>
    <PMID>12558312</PMID>
  </reference>
  <reference>
    <citation>Ward RA, Ouseph R: Modification of membrane characteristics allows a reduction in dialyzer membrane area without loss of performance. J Am Soc Nephrol 18:453A, 2007.</citation>
  </reference>
  <reference>
    <citation>Chen PS, Toribara TY, Warner H. Microdetermination of phosphorus. Anal Chem 1956; 28: 1756-1758</citation>
  </reference>
  <results_reference>
    <citation>Bhimani JP, Ouseph R, Ward RA. Effect of increasing dialysate flow rate on diffusive mass transfer of urea, phosphate and beta2-microglobulin during clinical haemodialysis. Nephrol Dial Transplant. 2010 Dec;25(12):3990-5. doi: 10.1093/ndt/gfq326. Epub 2010 Jun 13.</citation>
    <PMID>20543211</PMID>
  </results_reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2008</study_first_submitted>
  <study_first_submitted_qc>March 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2008</study_first_posted>
  <results_first_submitted>March 7, 2011</results_first_submitted>
  <results_first_submitted_qc>June 6, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 1, 2011</results_first_posted>
  <last_update_submitted>April 4, 2017</last_update_submitted>
  <last_update_submitted_qc>April 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hemodialysis</keyword>
  <keyword>Dialysis, Renal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dialysis Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>HD-C4 Big First</title>
          <description>Patients in this Arm will receive 3 consecutive treatments with the HD-C4 Big dialyzer first. For the study each patient will be treated for three consecutive treatments with each of the 4 study dialyzers (total of 12 consecutive treatments).</description>
        </group>
        <group group_id="P2">
          <title>HD-C4 Small First</title>
          <description>Patients in this Arm will receive 3 consecutive treatments with the HD-C4 Small dialyzer first. For the study each patient will be treated for three consecutive treatments with each of the 4 study dialyzers (total of 12 consecutive treatments).</description>
        </group>
        <group group_id="P3">
          <title>Optiflux F160NR First</title>
          <description>Patients in this Arm will receive 3 consecutive treatments with the F160NR dialyzer first. For the study each patient will be treated for three consecutive treatments with each of the 4 study dialyzers (total of 12 consecutive treatments).</description>
        </group>
        <group group_id="P4">
          <title>Optiflux F200NR First</title>
          <description>Patients in this Arm will receive 3 consecutive treatments with the F200NR dialyzer first. For the study each patient will be treated for three consecutive treatments with each of the 4 study dialyzers (total of 12 consecutive treatments).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Week 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Week 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Week 3</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Week 4</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60" lower_limit="32" upper_limit="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Effect of Increased Dialysate Flow Rate on KoA for Urea Between 4 Dialyzers With Different Membrane Packing Densities.</title>
        <description>KoA is a constant that describes the efficiency of a dialyzer in removing urea. KoA is determined by surface area of the membrane, the thickness of the membrane and pore size.</description>
        <time_frame>During the third treatment with each dialyzer (one time during each trial period week)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HD-C4 Big</title>
            <description>3 consecutive treatments with the HD-C4 Big dialyzer.</description>
          </group>
          <group group_id="O2">
            <title>HD-C4 Small</title>
            <description>3 consecutive treatments with the HD-C4 Small dialyzer.</description>
          </group>
          <group group_id="O3">
            <title>F160NR</title>
            <description>3 consecutive treatments with the F160NR dialyzer.</description>
          </group>
          <group group_id="O4">
            <title>F200NR</title>
            <description>3 consecutive treatments with the F200NR dialyzer.</description>
          </group>
        </group_list>
        <measure>
          <title>Effect of Increased Dialysate Flow Rate on KoA for Urea Between 4 Dialyzers With Different Membrane Packing Densities.</title>
          <description>KoA is a constant that describes the efficiency of a dialyzer in removing urea. KoA is determined by surface area of the membrane, the thickness of the membrane and pore size.</description>
          <units>KoA for urea (mL/min)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>350 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="844" spread="30"/>
                    <measurement group_id="O2" value="763" spread="34"/>
                    <measurement group_id="O3" value="770" spread="36"/>
                    <measurement group_id="O4" value="798" spread="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>500 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="898" spread="31"/>
                    <measurement group_id="O2" value="748" spread="34"/>
                    <measurement group_id="O3" value="738" spread="40"/>
                    <measurement group_id="O4" value="890" spread="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>800 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="922" spread="31"/>
                    <measurement group_id="O2" value="761" spread="25"/>
                    <measurement group_id="O3" value="809" spread="24"/>
                    <measurement group_id="O4" value="817" spread="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Effect of Increased Dialysate Flow Rate on Whole Blood Urea Clearance Between 4 Dialyzers With Different Membrane Packing Densities.</title>
        <time_frame>During the third treatment with each dialyzer (one time during each trial period week)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HD-C4 Big</title>
            <description>3 consecutive treatments with the HD-C4 Big dialyzer.</description>
          </group>
          <group group_id="O2">
            <title>HD-C4 Small</title>
            <description>3 consecutive treatments with the HD-C4 Small dialyzer.</description>
          </group>
          <group group_id="O3">
            <title>F160NR</title>
            <description>3 consecutive treatments with the F160NR dialyzer.</description>
          </group>
          <group group_id="O4">
            <title>F200NR</title>
            <description>3 consecutive treatments with the F200NR dialyzer.</description>
          </group>
        </group_list>
        <measure>
          <title>Effect of Increased Dialysate Flow Rate on Whole Blood Urea Clearance Between 4 Dialyzers With Different Membrane Packing Densities.</title>
          <units>Whole blood urea clearance (mL/min)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>350 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="279" spread="3"/>
                    <measurement group_id="O2" value="270" spread="4"/>
                    <measurement group_id="O3" value="271" spread="4"/>
                    <measurement group_id="O4" value="274" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>500 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="315" spread="3"/>
                    <measurement group_id="O2" value="295" spread="5"/>
                    <measurement group_id="O3" value="293" spread="8"/>
                    <measurement group_id="O4" value="313" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>800 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="340" spread="3"/>
                    <measurement group_id="O2" value="320" spread="3"/>
                    <measurement group_id="O3" value="313" spread="4"/>
                    <measurement group_id="O4" value="327" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Effect of Increased Dialysate Flow Rate on KoA for Phosphorus Between 4 Dialyzers With Different Membrane Packing Densities.</title>
        <time_frame>During the third treatment with each dialyzer (one time during each trial period week)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HD-C4 Big</title>
            <description>3 consecutive treatments with the HD-C4 Big dialyzer.</description>
          </group>
          <group group_id="O2">
            <title>HD-C4 Small</title>
            <description>3 consecutive treatments with the HD-C4 Small dialyzer.</description>
          </group>
          <group group_id="O3">
            <title>F160NR</title>
            <description>3 consecutive treatments with the F160NR dialyzer.</description>
          </group>
          <group group_id="O4">
            <title>F200NR</title>
            <description>3 consecutive treatments with the F200NR dialyzer.</description>
          </group>
        </group_list>
        <measure>
          <title>Effect of Increased Dialysate Flow Rate on KoA for Phosphorus Between 4 Dialyzers With Different Membrane Packing Densities.</title>
          <units>KoA for Phosphorus (mL/min)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>350 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="434" spread="48"/>
                    <measurement group_id="O2" value="334" spread="24"/>
                    <measurement group_id="O3" value="434" spread="34"/>
                    <measurement group_id="O4" value="504" spread="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>500 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="435" spread="31"/>
                    <measurement group_id="O2" value="422" spread="48"/>
                    <measurement group_id="O3" value="450" spread="62"/>
                    <measurement group_id="O4" value="491" spread="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>800 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="520" spread="39"/>
                    <measurement group_id="O2" value="415" spread="35"/>
                    <measurement group_id="O3" value="458" spread="33"/>
                    <measurement group_id="O4" value="560" spread="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Effect of Increased Dialysate Flow Rate on Whole Blood Phosphorus Clearance Between 4 Dialyzers With Different Membrane Packing Densities.</title>
        <time_frame>During the third treatment with each dialyzer (one time during each trial period week)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HD-C4 Big</title>
            <description>3 consecutive treatments with the HD-C4 Big dialyzer.</description>
          </group>
          <group group_id="O2">
            <title>HD-C4 Small</title>
            <description>3 consecutive treatments with the HD-C4 Small dialyzer.</description>
          </group>
          <group group_id="O3">
            <title>F160NR</title>
            <description>3 consecutive treatments with the F160NR dialyzer.</description>
          </group>
          <group group_id="O4">
            <title>F200NR</title>
            <description>3 consecutive treatments with the F200NR dialyzer.</description>
          </group>
        </group_list>
        <measure>
          <title>Effect of Increased Dialysate Flow Rate on Whole Blood Phosphorus Clearance Between 4 Dialyzers With Different Membrane Packing Densities.</title>
          <units>whole blood phosphorus clearance mL/min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>350 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="255" spread="7"/>
                    <measurement group_id="O2" value="252" spread="9"/>
                    <measurement group_id="O3" value="247" spread="6"/>
                    <measurement group_id="O4" value="249" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>500 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="269" spread="10"/>
                    <measurement group_id="O2" value="261" spread="9"/>
                    <measurement group_id="O3" value="260" spread="7"/>
                    <measurement group_id="O4" value="265" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>800 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="286" spread="7"/>
                    <measurement group_id="O2" value="273" spread="7"/>
                    <measurement group_id="O3" value="272" spread="7"/>
                    <measurement group_id="O4" value="281" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Effect of Increased Dialysate Flow Rate on KoA for b2-microglobulin Between 4 Dialyzers With Different Membrane Packing Densities.</title>
        <time_frame>During the third treatment with each dialyzer (one time during each trial period week)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HD-C4 Big</title>
            <description>3 consecutive treatments with the HD-C4 Big dialyzer.</description>
          </group>
          <group group_id="O2">
            <title>HD-C4 Small</title>
            <description>3 consecutive treatments with the HD-C4 Small dialyzer.</description>
          </group>
          <group group_id="O3">
            <title>F160NR</title>
            <description>3 consecutive treatments with the F160NR dialyzer.</description>
          </group>
          <group group_id="O4">
            <title>F200NR</title>
            <description>3 consecutive treatments with the F200NR dialyzer.</description>
          </group>
        </group_list>
        <measure>
          <title>Effect of Increased Dialysate Flow Rate on KoA for b2-microglobulin Between 4 Dialyzers With Different Membrane Packing Densities.</title>
          <units>KoA for b2-microglobulin (mL/min)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>350 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65" spread="4"/>
                    <measurement group_id="O2" value="61" spread="2"/>
                    <measurement group_id="O3" value="27" spread="2"/>
                    <measurement group_id="O4" value="27" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>500 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62" spread="3"/>
                    <measurement group_id="O2" value="57" spread="2"/>
                    <measurement group_id="O3" value="28" spread="2"/>
                    <measurement group_id="O4" value="25" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>800 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64" spread="3"/>
                    <measurement group_id="O2" value="56" spread="3"/>
                    <measurement group_id="O3" value="31" spread="5"/>
                    <measurement group_id="O4" value="21" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Effect of Increased Dialysate Flow Rate on Whole Blood B2-microglobulin Clearance Between 4 Dialyzers With Different Membrane Packing Densities.</title>
        <time_frame>During the third treatment with each dialyzer (one time during each trial period week)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HD-C4 Big</title>
            <description>3 consecutive treatments with the HD-C4 Big dialyzer.</description>
          </group>
          <group group_id="O2">
            <title>HD-C4 Small</title>
            <description>3 consecutive treatments with the HD-C4 Small dialyzer.</description>
          </group>
          <group group_id="O3">
            <title>F160NR</title>
            <description>3 consecutive treatments with the F160NR dialyzer.</description>
          </group>
          <group group_id="O4">
            <title>F200NR</title>
            <description>3 consecutive treatments with the F200NR dialyzer.</description>
          </group>
        </group_list>
        <measure>
          <title>Effect of Increased Dialysate Flow Rate on Whole Blood B2-microglobulin Clearance Between 4 Dialyzers With Different Membrane Packing Densities.</title>
          <units>whole blood clearance B2-microglobulin</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>350 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106" spread="9"/>
                    <measurement group_id="O2" value="119" spread="6"/>
                    <measurement group_id="O3" value="87" spread="6"/>
                    <measurement group_id="O4" value="72" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>500 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="129" spread="7"/>
                    <measurement group_id="O2" value="118" spread="8"/>
                    <measurement group_id="O3" value="86" spread="10"/>
                    <measurement group_id="O4" value="65" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>800 mL/min Dialysate Flow Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118" spread="7"/>
                    <measurement group_id="O2" value="121" spread="9"/>
                    <measurement group_id="O3" value="78" spread="8"/>
                    <measurement group_id="O4" value="75" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>HD-C4 Big</title>
          <description>3 consecutive treatments with the HD-C4 Big dialyzer.</description>
        </group>
        <group group_id="E2">
          <title>HD-C4 Small</title>
          <description>3 consecutive treatments with the HD-C4 Small dialyzer.</description>
        </group>
        <group group_id="E3">
          <title>F160NR</title>
          <description>3 consecutive treatments with the F160NR dialyzer.</description>
        </group>
        <group group_id="E4">
          <title>F200NR</title>
          <description>3 consecutive treatments with the F200NR dialyzer.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Richard A Ward, Ph.D.</name_or_title>
      <organization>Kidney Disease Program, University of Louisville</organization>
      <phone>502-852-5757</phone>
      <email>richard.ward@louisville.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

